EGFR and glioblastoma: A batch of outstanding publications related to the potent antitumor activity of PTs through diverse mechanisms (e.g., EGFR signaling) [19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37] prompted us to identify EGFR-targeted PTs for the treatment of GBM.